Uveitis

Risk factors for ocular toxoplasmosis among uveitis patients in Kinshasa, DR Congo
Nadine Nsiangani Lusambo, Dieudonné Kaimbo Wa Kaimbo, Dieudonné Mumba Ngoyi, Pierre Akilimali Zalagile, Alejandra de-la-Torre

BMJ Open Ophthalmology Jan 2023, 8 (1) e001198; DOI: 10.1136/bmjophth-2022-001198
Colombian ocular inflammatory diseases epidemiology study (COIDES): prevalence, incidence and sociodemographic characterisation of Scleritis in Colombia, 2015–2020
Carlos Cifuentes-González, William Rojas-Carabali, Germán Mejia-Salgado, Juan Sebastián Pineda-Sierra, Paula Tatiana Muñoz-Vargas, Laura Boada-Robayo, Danna Lesley Cruz, Alejandra de-la-Torre

BMJ Open Ophthalmology Nov 2022, 7 (1) e001096; DOI: 10.1136/bmjophth-2022-001096
Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer’s perspective
Seenu M Hariprasad, George Joseph, Patrick Gagnon-Sanschagrin, Elizabeth Serra, Subrata Bhattacharyya, Jérôme Bédard, Annie Guérin, Thomas Arno Albini

BMJ Open Ophthalmology Nov 2021, 6 (1) e000896; DOI: 10.1136/bmjophth-2021-000896
Adalimumab in patients with vision-threatening uveitis: real-world clinical experience
Timothy Lee Tang Lee Say, Verlyn Yang, Jacob M Fingret, Sophia Zagora, Richard Symes, Christine Younan, Elisa Eleanor Cornish, Nitin Verma, Anthony Sammel, Denis Wakefield, Deborah Speden, Peter J McCluskey

BMJ Open Ophthalmology Sep 2021, 6 (1) e000819; DOI: 10.1136/bmjophth-2021-000819

Main menu